Hill-Rom Holdings, Inc. (HRC) Stake Boosted by Sio Capital Management LLC
Sio Capital Management LLC grew its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 12.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 24,036 shares of the medical technology company’s stock after purchasing an additional 2,587 shares during the period. Sio Capital Management LLC’s holdings in Hill-Rom were worth $2,269,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the company. Legal & General Group Plc increased its stake in shares of Hill-Rom by 0.9% in the 2nd quarter. Legal & General Group Plc now owns 86,984 shares of the medical technology company’s stock valued at $7,597,000 after purchasing an additional 767 shares during the last quarter. Creative Planning increased its stake in shares of Hill-Rom by 4.0% in the 3rd quarter. Creative Planning now owns 20,694 shares of the medical technology company’s stock valued at $1,954,000 after purchasing an additional 794 shares during the last quarter. Yorktown Management & Research Co Inc increased its stake in shares of Hill-Rom by 34.8% in the 3rd quarter. Yorktown Management & Research Co Inc now owns 3,100 shares of the medical technology company’s stock valued at $293,000 after purchasing an additional 800 shares during the last quarter. GSA Capital Partners LLP increased its stake in shares of Hill-Rom by 19.9% in the 3rd quarter. GSA Capital Partners LLP now owns 4,980 shares of the medical technology company’s stock valued at $470,000 after purchasing an additional 826 shares during the last quarter. Finally, Swiss National Bank increased its stake in shares of Hill-Rom by 0.8% in the 3rd quarter. Swiss National Bank now owns 115,600 shares of the medical technology company’s stock valued at $10,913,000 after purchasing an additional 900 shares during the last quarter. Institutional investors own 82.57% of the company’s stock.
Several equities analysts have recently issued reports on the company. Zacks Investment Research lowered Hill-Rom from a “buy” rating to a “hold” rating and set a $111.00 price target on the stock. in a research note on Wednesday, December 5th. ValuEngine upgraded Hill-Rom from a “hold” rating to a “buy” rating in a research note on Tuesday, November 6th. Raymond James raised their price objective on Hill-Rom from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Monday, November 5th. UBS Group began coverage on Hill-Rom in a report on Tuesday, November 27th. They set a “buy” rating and a $115.00 price objective on the stock. Finally, Morgan Stanley raised their price objective on Hill-Rom from $95.00 to $100.00 and gave the company an “equal weight” rating in a report on Thursday, October 11th. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $104.00.
NYSE HRC opened at $96.25 on Thursday. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.30 and a current ratio of 1.74. Hill-Rom Holdings, Inc. has a twelve month low of $78.16 and a twelve month high of $99.81. The firm has a market cap of $6.32 billion, a P/E ratio of 20.26, a PEG ratio of 1.31 and a beta of 0.94.
Hill-Rom (NYSE:HRC) last released its quarterly earnings data on Friday, November 2nd. The medical technology company reported $1.63 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.12. Hill-Rom had a return on equity of 21.10% and a net margin of 8.86%. The company had revenue of $759.20 million for the quarter, compared to the consensus estimate of $750.90 million. During the same quarter last year, the business posted $1.32 EPS. Hill-Rom’s revenue for the quarter was up 2.8% on a year-over-year basis. On average, analysts forecast that Hill-Rom Holdings, Inc. will post 5.13 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 31st. Investors of record on Friday, December 14th will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 0.83%. The ex-dividend date of this dividend is Thursday, December 13th. Hill-Rom’s dividend payout ratio (DPR) is 16.84%.
TRADEMARK VIOLATION NOTICE: “Hill-Rom Holdings, Inc. (HRC) Stake Boosted by Sio Capital Management LLC” was published by Daily Political and is the property of of Daily Political. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.dailypolitical.com/2018/12/13/hill-rom-holdings-inc-hrc-stake-boosted-by-sio-capital-management-llc.html.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.